ID   AL9A1_HUMAN             Reviewed;         494 AA.
AC   P49189; B2R6X1; B4DXY7; Q5VV90; Q6LCL1; Q9NZT7;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 3.
DT   10-MAY-2017, entry version 161.
DE   RecName: Full=4-trimethylaminobutyraldehyde dehydrogenase;
DE            Short=TMABADH;
DE            EC=1.2.1.47;
DE   AltName: Full=Aldehyde dehydrogenase E3 isozyme;
DE   AltName: Full=Aldehyde dehydrogenase family 9 member A1;
DE            EC=1.2.1.3;
DE   AltName: Full=Gamma-aminobutyraldehyde dehydrogenase;
DE            EC=1.2.1.19;
DE   AltName: Full=R-aminobutyraldehyde dehydrogenase;
DE   Contains:
DE     RecName: Full=4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed;
GN   Name=ALDH9A1; Synonyms=ALDH4, ALDH7, ALDH9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT SER-116.
RC   TISSUE=Liver;
RX   PubMed=8786138; DOI=10.1006/geno.1996.0300;
RA   Lin S.W., Chen J.C., Hsu L.C., Hsieh C.-L., Yoshida A.;
RT   "Human gamma-aminobutyraldehyde dehydrogenase (ALDH9): cDNA sequence,
RT   genomic organization, polymorphism, chromosomal localization, and
RT   tissue expression.";
RL   Genomics 34:376-380(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Liver;
RX   PubMed=10702312; DOI=10.1074/jbc.275.10.7390;
RA   Vaz F.M., Fouchier S.W., Ofman R., Sommer M., Wanders R.J.A.;
RT   "Molecular and biochemical characterization of rat gamma-
RT   trimethylaminobutyraldehyde dehydrogenase and evidence for the
RT   involvement of human aldehyde dehydrogenase 9 in carnitine
RT   biosynthesis.";
RL   J. Biol. Chem. 275:7390-7394(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Spleen, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   PROTEIN SEQUENCE OF 2-15; 247-258; 299-310; 315-326 AND 472-481,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [6]
RP   PROTEIN SEQUENCE OF 259-274; 353-366; 412-426 AND 434-453, NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 29-494, CHARACTERIZATION, TISSUE SPECIFICITY, AND
RP   VARIANT SER-116.
RC   TISSUE=Brain;
RX   PubMed=8645224; DOI=10.1042/bj3160317;
RA   Kikonyogo A., Pietruszko R.;
RT   "Aldehyde dehydrogenase from adult human brain that dehydrogenates
RT   gamma-aminobutyraldehyde: purification, characterization, cloning and
RT   distribution.";
RL   Biochem. J. 316:317-324(1996).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 33-494 (ISOFORM 1), AND PARTIAL PROTEIN
RP   SEQUENCE.
RX   PubMed=8269919; DOI=10.1111/j.1432-1033.1993.tb18379.x;
RA   Kurys G., Shah P.C., Kikonyogo A., Reed D., Ambroziak W.,
RA   Pietruszko R.;
RT   "Human aldehyde dehydrogenase. cDNA cloning and primary structure of
RT   the enzyme that catalyzes dehydrogenation of 4-aminobutyraldehyde.";
RL   Eur. J. Biochem. 218:311-320(1993).
RN   [8]
RP   CHARACTERIZATION.
RC   TISSUE=Liver;
RX   PubMed=2925663;
RA   Kurys G., Ambroziak W., Pietruszko R.;
RT   "Human aldehyde dehydrogenase. Purification and characterization of a
RT   third isozyme with low Km for gamma-aminobutyraldehyde.";
RL   J. Biol. Chem. 264:4715-4721(1989).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-298, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Converts gamma-trimethylaminobutyraldehyde into gamma-
CC       butyrobetaine. Catalyzes the irreversible oxidation of a broad
CC       range of aldehydes to the corresponding acids in an NAD-dependent
CC       reaction. {ECO:0000269|PubMed:10702312}.
CC   -!- CATALYTIC ACTIVITY: 4-trimethylammoniobutanal + NAD(+) + H(2)O =
CC       4-trimethylammoniobutanoate + NADH.
CC   -!- CATALYTIC ACTIVITY: An aldehyde + NAD(+) + H(2)O = a carboxylate +
CC       NADH.
CC   -!- CATALYTIC ACTIVITY: 4-aminobutanal + NAD(+) + H(2)O = 4-
CC       aminobutanoate + NADH.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=11 uM for 4-aminobutyraldehyde;
CC       pH dependence:
CC         Optimum pH is about 9.4 with propionaldehyde as substrate, and
CC         7.5 with 4-aminobutyraldehyde as substrate.;
CC   -!- PATHWAY: Amine and polyamine biosynthesis; carnitine biosynthesis.
CC   -!- SUBUNIT: Homotetramer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P49189-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49189-2; Sequence=VSP_056305;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: High expression in adult liver, skeletal
CC       muscle, and kidney. Low levels in heart, pancreas, lung and brain.
CC       Expressed in all regions of the brain. Expression levels are
CC       variable in the different brain areas, with the highest levels in
CC       the spinal cord and the lowest in the occipital pole.
CC       {ECO:0000269|PubMed:8645224}.
CC   -!- DEVELOPMENTAL STAGE: Strongly expressed in human embryonic brain
CC       (gestational age 12 weeks).
CC   -!- SIMILARITY: Belongs to the aldehyde dehydrogenase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAH74061.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U34252; AAB18827.1; -; mRNA.
DR   EMBL; AF172093; AAF43600.1; -; mRNA.
DR   EMBL; AK302183; BAG63549.1; -; mRNA.
DR   EMBL; AK302191; BAG63554.1; -; mRNA.
DR   EMBL; AK312751; BAG35618.1; -; mRNA.
DR   EMBL; AL451074; CAH74061.1; ALT_INIT; Genomic_DNA.
DR   EMBL; U50203; AAB06721.1; -; mRNA.
DR   EMBL; X75425; CAA53176.1; -; mRNA.
DR   PIR; G02054; S39532.
DR   RefSeq; NP_000687.3; NM_000696.3.
DR   RefSeq; XP_011507596.1; XM_011509294.2. [P49189-2]
DR   UniGene; Hs.2533; -.
DR   ProteinModelPortal; P49189; -.
DR   SMR; P49189; -.
DR   BioGrid; 106725; 16.
DR   IntAct; P49189; 5.
DR   MINT; MINT-5006004; -.
DR   STRING; 9606.ENSP00000346827; -.
DR   ChEMBL; CHEMBL3542434; -.
DR   DrugBank; DB00157; NADH.
DR   iPTMnet; P49189; -.
DR   PhosphoSitePlus; P49189; -.
DR   SwissPalm; P49189; -.
DR   BioMuta; ALDH9A1; -.
DR   DMDM; 62511242; -.
DR   REPRODUCTION-2DPAGE; IPI00479877; -.
DR   EPD; P49189; -.
DR   MaxQB; P49189; -.
DR   PaxDb; P49189; -.
DR   PeptideAtlas; P49189; -.
DR   PRIDE; P49189; -.
DR   DNASU; 223; -.
DR   Ensembl; ENST00000354775; ENSP00000346827; ENSG00000143149.
DR   Ensembl; ENST00000538148; ENSP00000440026; ENSG00000143149.
DR   GeneID; 223; -.
DR   KEGG; hsa:223; -.
DR   UCSC; uc001gdh.2; human. [P49189-1]
DR   CTD; 223; -.
DR   DisGeNET; 223; -.
DR   GeneCards; ALDH9A1; -.
DR   H-InvDB; HIX0199965; -.
DR   HGNC; HGNC:412; ALDH9A1.
DR   HPA; HPA006077; -.
DR   HPA; HPA010873; -.
DR   MIM; 602733; gene.
DR   neXtProt; NX_P49189; -.
DR   PharmGKB; PA24706; -.
DR   eggNOG; KOG2450; Eukaryota.
DR   eggNOG; COG1012; LUCA.
DR   HOVERGEN; HBG000097; -.
DR   InParanoid; P49189; -.
DR   KO; K00149; -.
DR   OrthoDB; EOG091G05E8; -.
DR   PhylomeDB; P49189; -.
DR   TreeFam; TF314257; -.
DR   BioCyc; MetaCyc:HS06992-MONOMER; -.
DR   BRENDA; 1.2.1.47; 2681.
DR   Reactome; R-HSA-71262; Carnitine synthesis.
DR   SABIO-RK; P49189; -.
DR   UniPathway; UPA00118; -.
DR   ChiTaRS; ALDH9A1; human.
DR   GeneWiki; Aldehyde_dehydrogenase_9_family,_member_A1; -.
DR   GenomeRNAi; 223; -.
DR   PRO; PR:P49189; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143149; -.
DR   CleanEx; HS_ALDH9A1; -.
DR   ExpressionAtlas; P49189; baseline and differential.
DR   Genevisible; P49189; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0033737; F:1-pyrroline dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004028; F:3-chloroallyl aldehyde dehydrogenase activity; TAS:Reactome.
DR   GO; GO:0047105; F:4-trimethylammoniobutyraldehyde dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004029; F:aldehyde dehydrogenase (NAD) activity; IDA:UniProtKB.
DR   GO; GO:0019145; F:aminobutyraldehyde dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0045329; P:carnitine biosynthetic process; TAS:Reactome.
DR   GO; GO:0006081; P:cellular aldehyde metabolic process; IDA:UniProtKB.
DR   GO; GO:0042445; P:hormone metabolic process; TAS:UniProtKB.
DR   GO; GO:0042136; P:neurotransmitter biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:UniProtKB.
DR   Gene3D; 3.40.605.10; -; 1.
DR   InterPro; IPR016161; Ald_DH/histidinol_DH.
DR   InterPro; IPR016160; Ald_DH_CS_CYS.
DR   InterPro; IPR029510; Ald_DH_CS_GLU.
DR   InterPro; IPR016162; Ald_DH_N.
DR   InterPro; IPR015590; Aldehyde_DH_dom.
DR   Pfam; PF00171; Aldedh; 1.
DR   SUPFAM; SSF53720; SSF53720; 1.
DR   PROSITE; PS00070; ALDEHYDE_DEHYDR_CYS; 1.
DR   PROSITE; PS00687; ALDEHYDE_DEHYDR_GLU; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; NAD; Oxidoreductase; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    494       4-trimethylaminobutyraldehyde
FT                                dehydrogenase.
FT                                /FTId=PRO_0000434351.
FT   INIT_MET      1      1       Removed; alternate.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.5}.
FT   CHAIN         2    494       4-trimethylaminobutyraldehyde
FT                                dehydrogenase, N-terminally processed.
FT                                /FTId=PRO_0000056485.
FT   NP_BIND     232    237       NAD. {ECO:0000250}.
FT   ACT_SITE    254    254       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10007, ECO:0000255|PROSITE-
FT                                ProRule:PRU10008}.
FT   ACT_SITE    288    288       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10007, ECO:0000255|PROSITE-
FT                                ProRule:PRU10008}.
FT   SITE        157    157       Transition state stabilizer.
FT                                {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylserine; in 4-
FT                                trimethylaminobutyraldehyde
FT                                dehydrogenase, N-terminally processed.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.5}.
FT   MOD_RES      30     30       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JLJ2}.
FT   MOD_RES      30     30       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JLJ2}.
FT   MOD_RES      59     59       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9JLJ2}.
FT   MOD_RES     298    298       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     303    303       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JLJ2}.
FT   MOD_RES     303    303       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9JLJ2}.
FT   MOD_RES     344    344       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9JLJ2}.
FT   VAR_SEQ       1     70       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056305.
FT   VARIANT     116    116       C -> S (in allele ALDH9A1*2).
FT                                {ECO:0000269|PubMed:8645224,
FT                                ECO:0000269|PubMed:8786138}.
FT                                /FTId=VAR_011304.
FT   CONFLICT     19     25       RVEPADA -> AGAGGR (in Ref. 1; AAB18827).
FT                                {ECO:0000305}.
FT   CONFLICT    150    150       C -> Q (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    159    159       P -> W (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    172    172       A -> R (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
SQ   SEQUENCE   494 AA;  53802 MW;  1E1CDF910D763BA1 CRC64;
     MSTGTFVVSQ PLNYRGGARV EPADASGTEK AFEPATGRVI ATFTCSGEKE VNLAVQNAKA
     AFKIWSQKSG MERCRILLEA ARIIREREDE IATMECINNG KSIFEARLDI DISWQCLEYY
     AGLAASMAGE HIQLPGGSFG YTRREPLGVC VGIGAWNYPF QIASWKSAPA LACGNAMVFK
     PSPFTPVSAL LLAEIYSEAG VPPGLFNVVQ GGAATGQFLC QHPDVAKVSF TGSVPTGMKI
     MEMSAKGIKP VTLELGGKSP LIIFSDCDMN NAVKGALMAN FLTQGQVCCN GTRVFVQKEI
     LDKFTEEVVK QTQRIKIGDP LLEDTRMGPL INRPHLERVL GFVKVAKEQG AKVLCGGDIY
     VPEDPKLKDG YYMRPCVLTN CRDDMTCVKE EIFGPVMSIL SFDTEAEVLE RANDTTFGLA
     AGVFTRDIQR AHRVVAELQA GTCFINNYNV SPVELPFGGY KKSGFGRENG RVTIEYYSQL
     KTVCVEMGDV ESAF
//
